Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins
- PMID: 2521328
- DOI: 10.1016/s0015-0282(16)60435-1
Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins
Abstract
To avoid cancellation of in vitro fertilization (IVF) because of early luteinization, pituitary suppression by gonadotropin-releasing hormone (GnRH) was carried out in 111 cycles. D-Trp-6-luteinizing hormone-releasing hormone (LH-RH) microcapsules were administered intramuscularly at menstruation and menotropin (hMG) stimulation was started 19 days (mean) later. In 3 cycles (2.7%), only early luteinization occurred. The mean number of oocytes per cycle was 6.7, with a fertilization and cleavage rate of 50 and 95%, respectively. A mean of 3.4 embryos were transferred per cycle. The 111 cycles resulted in 34 clinical pregnancies, 41% per cycle with embryo transfer. The early abortion, multiple pregnancy, and ovarian hyperstimulation rates were 24, 18, and 11%, respectively. It is concluded that D-Trp-6-LH-RH/hMG cycles are associated with a very low occurrence of early luteinization, high number of oocytes and embryos, and a substantial incidence of ovarian hyperstimulation syndrome.
Similar articles
-
The use of gonadotropin-releasing hormone analogs for in vitro fertilization: comparison between the standard form and long-acting formulation of D-Trp-6-luteinizing hormone-releasing hormone.Fertil Steril. 1989 Jan;51(1):100-4. doi: 10.1016/s0015-0282(16)60436-3. Fertil Steril. 1989. PMID: 2521322
-
Ovarian hyperstimulation syndrome following D-Trp-6 luteinizing hormone-releasing hormone microcapsules and menotropin for in vitro fertilization.Fertil Steril. 1988 Dec;50(6):912-6. doi: 10.1016/s0015-0282(16)60371-0. Fertil Steril. 1988. PMID: 2974429
-
A comparison of clomiphene/menotropins and D-Trp6-LH-RH/menotropins cycles of IVF-ET in the same patients.Int J Fertil. 1991 May-Jun;36(3):157-61. Int J Fertil. 1991. PMID: 1678370
-
The prevention of ovarian hyperstimulation syndrome.J Obstet Gynaecol Can. 2014 Nov;36(11):1024-1033. doi: 10.1016/S1701-2163(15)30417-5. J Obstet Gynaecol Can. 2014. PMID: 25574681 Review. English, French.
-
In vitro fertilisation. A review of drug therapy and clinical management.Drugs. 1996 Sep;52(3):313-43. doi: 10.2165/00003495-199652030-00002. Drugs. 1996. PMID: 8875126 Review.
Cited by
-
Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study.J In Vitro Fert Embryo Transf. 1990 Dec;7(6):358-62; discussion 363-4. doi: 10.1007/BF01130591. J In Vitro Fert Embryo Transf. 1990. PMID: 2127604 Clinical Trial.
-
Lipoxygenase inhibitors shift the yeast/mycelium dimorphism in Ceratocystis ulmi.Appl Environ Microbiol. 1992 Aug;58(8):2505-8. doi: 10.1128/aem.58.8.2505-2508.1992. Appl Environ Microbiol. 1992. PMID: 1514797 Free PMC article.
-
Clinical outcome of one-third-dose depot triptorelin is the same as half-dose depot triptorelin in the long protocol of controlled ovarian stimulation.J Hum Reprod Sci. 2012 Jan;5(1):14-9. doi: 10.4103/0974-1208.97785. J Hum Reprod Sci. 2012. PMID: 22870009 Free PMC article.
-
Follicular aspiration does not protect against the development of ovarian hyperstimulation syndrome.J Assist Reprod Genet. 1992 Jun;9(3):238-43. doi: 10.1007/BF01203820. J Assist Reprod Genet. 1992. PMID: 1525453
-
The use of long-acting gonadotropin-releasing hormone agonist (GnRH-a; decapeptyl) and gonadotropins versus short-acting GnRH-a (buserelin) and gonadotropins before and during ovarian stimulation for in vitro fertilization (IVF).J In Vitro Fert Embryo Transf. 1991 Oct;8(5):254-9. doi: 10.1007/BF01139780. J In Vitro Fert Embryo Transf. 1991. PMID: 1836810 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources